Finance Business Partner - US General Medicines

Finance Business Partner - US General Medicines

Join to apply for the Finance Business Partner - US General Medicines role at Sanofi

Job Title: Finance Business Partner - US General Medicines

Location: Morristown, NJ

Ready to push the limits of what’s possible? Join Sanofi in one of our corporate functions and you can play a vital part in the performance of our entire business while helping to make an impact on millions around the world.

The Finance Business Partner - US General Medicines (Established Products and Medical Affairs) serves as a key finance partner, driving financial management and performance analysis for the US Gen Med EP and Medical Affairs teams. This role is critical to enabling data‑driven decision‑making and optimizing resource allocation across commercial and medical operations.

The ideal candidate is a proactive, analytical, and business‑savvy finance professional who excels in complex, matrixed environments. A trusted advisor, the FBP will forge strong partnerships across Marketing, Go‑To‑Market Capabilities, Patient Support Services, Market Access, Procurement, and Medical Affairs – translating financial insights into actionable business actions supporting our patient‑focused mission.

This FBP is an AI‑first champion and will leverage Sanofi's digital tools and platforms to enhance analytical capabilities, automate processes, and deliver faster, more insightful financial intelligence.

We’re an R&D‑driven, AI‑powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

• Lead financial partnership for US Gen Meds Essentials and Tail portfolios, and Medical Affairs team
• Deliver insightful analysis and reporting to drive informed decision‑making
• Guide budgeting, forecasting, and investment evaluation processes
• Optimize resource allocation and headcount planning and management

• Manage rolling forecast and key planning submissions
• Leverage AI and digital platforms to develop advanced financial reporting
• Analyze performance against targets, communicating key drivers to stakeholders
• Proactively identify and manage portfolio risks and opportunities
• Ensure alignment with broader US Gen Meds portfolio strategies

• Own month‑end close processes for Essentials, Tail, and Medical Affairs P&Ls
• Coordinate with Global, A2R, OpEx Hub, and other key teams
• Uphold data quality, compliance, and adherence to internal controls

• Serve as a subject‑matter expert on key financial systems
• Maintain relevant cost center hierarchies to enable efficient reporting and ensure data integrity
• Champion AI‑led forecasting and analytics and process simplification

• 4–7 years of experience in business finance, with a focus on financial analysis, budgeting, forecasting, and performance management
• Bachelor’s degree in accounting or finance, or relevant discipline
• AI and Digital first mindset
• Ability to thrive in a fast‑paced, complex organizational environment
• Strong communication and stakeholder management skills

• MBA, MS, or relevant advanced degree
• CMA, CPA, CGMA, or relevant professional designation
• Knowledge of Sanofi processes, systems and control framework
• Industry‑related experience

• Bring the miracles of science to life alongside a supportive, future‑focused team.
• Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.
• Enjoy a thoughtful, well‑crafted rewards package that recognizes your contribution and amplifies your impact.
• Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high‑quality healthcare, prevention and wellness programs and at least 14 weeks’ gender‑neutral parental leave.

Sanofi Inc. and its U.S.…